Lenz & Staehelin represented Stallergenes Greer plc (Euronext: STAGR), a global biopharmaceutical company specializing in treatments for respiratory allergies, in connection with a new revolving credit facility provided by UBS Switzerland AG.

The Lenz & Staehelin team was led by Marcel Tranchet and included Charlotte Rüegg and Christian Schneiter.